Literature DB >> 1899022

Substitution of histidine-84 and the GTPase mechanism of elongation factor Tu.

R H Cool1, A Parmeggiani.   

Abstract

Mutation of His84, a residue situated in one of the loops forming the guanine nucleotide binding pocket, was introduced in the G domain, the isolated N-terminal half molecule of bacterial elongation factor Tu (EF-Tu), in order to investigate the role of this residue on the basic activities of EF-Tu: the interaction with GDP and GTP and the hydrolysis of GTP. Substitution of His84 by Gly reduces the GTPase activity of the G domain to 5%; this activity can still be stimulated by raising the KCl concentration as the activity of wild-type G domain or the intact molecule. Since the affinities of the mutant protein for GDP and GTP are essentially the same as those of the wild-type G domain, His84 is apparently not involved in the binding of the substrates. Calculations of the change in free energy of activation of the GTPase reaction following substitution of His84 by Gly point to the disruption of a weak hydrogen bond, involved in the catalytic reaction. This probably concerns an interaction via a water molecule. The possible mechanism underlying the GTPase reaction is discussed in light of the three-dimensional structure of EF-Tu, taking into account the situation of Ha-ras p21.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1899022     DOI: 10.1021/bi00216a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination.

Authors:  Joe Salas-Marco; David M Bedwell
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

2.  Crystal structure of release factor RF3 trapped in the GTP state on a rotated conformation of the ribosome.

Authors:  Jie Zhou; Laura Lancaster; Sergei Trakhanov; Harry F Noller
Journal:  RNA       Date:  2011-12-20       Impact factor: 4.942

Review 3.  smFRET studies of the 'encounter' complexes and subsequent intermediate states that regulate the selectivity of ligand binding.

Authors:  Colin D Kinz-Thompson; Ruben L Gonzalez
Journal:  FEBS Lett       Date:  2014-07-24       Impact factor: 4.124

Review 4.  Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-Tu.

Authors:  Xabier Agirrezabala; Joachim Frank
Journal:  Q Rev Biophys       Date:  2009-08       Impact factor: 5.318

5.  Converting structural information into an allosteric-energy-based picture for elongation factor Tu activation by the ribosome.

Authors:  Andrew J Adamczyk; Arieh Warshel
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-26       Impact factor: 11.205

Review 6.  Why nature really chose phosphate.

Authors:  Shina C L Kamerlin; Pankaz K Sharma; Ram B Prasad; Arieh Warshel
Journal:  Q Rev Biophys       Date:  2013-01-15       Impact factor: 5.318

7.  Mechanism of the chemical step for the guanosine triphosphate (GTP) hydrolysis catalyzed by elongation factor Tu.

Authors:  B L Grigorenko; M S Shadrina; I A Topol; J R Collins; A V Nemukhin
Journal:  Biochim Biophys Acta       Date:  2008-08-16

8.  Addressing open questions about phosphate hydrolysis pathways by careful free energy mapping.

Authors:  B Ram Prasad; Nikolay V Plotnikov; Arieh Warshel
Journal:  J Phys Chem B       Date:  2012-12-28       Impact factor: 2.991

9.  A conserved PUF-Ago-eEF1A complex attenuates translation elongation.

Authors:  Kyle Friend; Zachary T Campbell; Amy Cooke; Peggy Kroll-Conner; Marvin P Wickens; Judith Kimble
Journal:  Nat Struct Mol Biol       Date:  2012-01-08       Impact factor: 15.369

10.  Structure of the protein core of translation initiation factor 2 in apo, GTP-bound and GDP-bound forms.

Authors:  Angelita Simonetti; Stefano Marzi; Attilio Fabbretti; Isabelle Hazemann; Lasse Jenner; Alexandre Urzhumtsev; Claudio O Gualerzi; Bruno P Klaholz
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.